DK27097A - Minactivin og fremgangsmåde til fremstilling deraf - Google Patents

Minactivin og fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK27097A
DK27097A DK027097A DK27097A DK27097A DK 27097 A DK27097 A DK 27097A DK 027097 A DK027097 A DK 027097A DK 27097 A DK27097 A DK 27097A DK 27097 A DK27097 A DK 27097A
Authority
DK
Denmark
Prior art keywords
minactivin
purification
biologically active
relates
preparation
Prior art date
Application number
DK027097A
Other languages
English (en)
Inventor
Toni Marie Antails
Tomas Michael Barnes
Michelle Alison Clark
Original Assignee
Biotech Australia Pty Ltd
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Australian filed Critical Biotech Australia Pty Ltd
Publication of DK27097A publication Critical patent/DK27097A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9723—Urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
DK027097A 1986-03-13 1997-03-13 Minactivin og fremgangsmåde til fremstilling deraf DK27097A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPH501786 1986-03-13
AUPH603386 1986-05-22
AUPH810086 1986-09-18
AUPH910486 1986-11-21

Publications (1)

Publication Number Publication Date
DK27097A true DK27097A (da) 1997-03-13

Family

ID=27424177

Family Applications (2)

Application Number Title Priority Date Filing Date
DK595187A DK172400B1 (da) 1986-03-13 1987-11-13 Fremgangsmåde til fremstilling af renset minactivin, minactivinkodende DNA-molekyle, rekombinant DNA-molekyle, sammensmeltet gen, vært, reagent til lokalisering og definering af grænserne for tumorer i histologiske prøver, samt anvendelse af det rekombinante DNA-molekyle, minactivinet og peptider deraf
DK027097A DK27097A (da) 1986-03-13 1997-03-13 Minactivin og fremgangsmåde til fremstilling deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK595187A DK172400B1 (da) 1986-03-13 1987-11-13 Fremgangsmåde til fremstilling af renset minactivin, minactivinkodende DNA-molekyle, rekombinant DNA-molekyle, sammensmeltet gen, vært, reagent til lokalisering og definering af grænserne for tumorer i histologiske prøver, samt anvendelse af det rekombinante DNA-molekyle, minactivinet og peptider deraf

Country Status (13)

Country Link
US (1) US5426044A (da)
EP (1) EP0238275B1 (da)
JP (2) JP2589996B2 (da)
KR (1) KR960001820B1 (da)
CN (2) CN1032019C (da)
AT (1) ATE132192T1 (da)
CA (1) CA1338381C (da)
DE (1) DE3751646T2 (da)
DK (2) DK172400B1 (da)
IL (1) IL81879A (da)
NO (1) NO178504C (da)
NZ (1) NZ219608A (da)
WO (1) WO1987005628A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
WO1991003556A1 (en) * 1989-09-05 1991-03-21 Biotechnology Australia Pty Ltd Recombinant product
WO1991009124A1 (en) * 1989-12-20 1991-06-27 Biotech Australia Pty. Limited Variants of pai-2
GB9026737D0 (en) * 1990-12-08 1991-01-30 Delta Biotechnology Ltd Cancer treatment
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
CN102586187A (zh) * 2012-02-23 2012-07-18 深圳市中美康士生物科技有限公司 一种中性粒细胞体外保存方法及培养基
CN116375796A (zh) * 2022-11-24 2023-07-04 华南农业大学 一种来源于珍珠贝的抗炎肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
WO1986001212A1 (en) * 1984-08-13 1986-02-27 Biotechnology Australia Pty. Ltd. Minactivin
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation

Also Published As

Publication number Publication date
CN1032019C (zh) 1996-06-12
NO178504B (no) 1996-01-02
NO874704L (no) 1987-11-11
DK172400B1 (da) 1998-05-18
DE3751646T2 (de) 1996-10-17
NZ219608A (en) 1991-05-28
US5426044A (en) 1995-06-20
DK595187D0 (da) 1987-11-13
KR960001820B1 (ko) 1996-02-05
ATE132192T1 (de) 1996-01-15
EP0238275B1 (en) 1995-12-27
IL81879A (en) 1994-07-31
JPH08112094A (ja) 1996-05-07
KR880701073A (ko) 1988-07-25
WO1987005628A1 (en) 1987-09-24
CN87102725A (zh) 1987-11-11
CN1100957A (zh) 1995-04-05
CA1338381C (en) 1996-06-11
JP2589996B2 (ja) 1997-03-12
EP0238275A3 (en) 1989-05-10
DE3751646D1 (de) 1996-02-08
JPS63503354A (ja) 1988-12-08
EP0238275A2 (en) 1987-09-23
JP2660681B2 (ja) 1997-10-08
NO178504C (no) 1996-04-10
DK595187A (da) 1988-07-21
NO874704D0 (no) 1987-11-11

Similar Documents

Publication Publication Date Title
FI100056B (fi) Ihmisproapolipoproteiinin A-I ilmaiseminen
ATE386800T1 (de) Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
DE3650645D1 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
NO863000L (no) Fusjonsproteiner og fremgangsmaate til fremstilling derav.
NO875136D0 (no) Heste - gamma - interferon.
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
FI880017A0 (fi) Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu
DE69434839D1 (de) Transferrin-rezeptor gene von haemophilus
DK595187D0 (da) Minactivin og fremgangsmaade til fremstilling deraf
NO930428L (no) Proteinstrukturen til plantetoksingelonin
ATE163651T1 (de) Neues menschliches, rekombinantes interferon gamma
ES2009588A6 (es) Un metodo para la preparacion de un polipeptido.
DE69737766D1 (de) Zusammensetzungen von stammzellfaktor (scf)-analogen und auf diese bezogene verfahren
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
ATE79638T1 (de) Polypeptide, deren kodierende peptide und methode zur herstellung dieser peptide und dnas.
DK210288D0 (da) Overproduktion af exocelllulaere proteiner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment